Bangladesh vs Indonesia: Antiretroviral therapy coverage
Bangladesh
41.0%
in 2024
Indonesia
41.0%
in 2024
Bangladesh rank
131st
Indonesia rank
131st
Antiretroviral therapy coverage over time
- Bangladesh
- Indonesia
How they compare
Bangladesh currently reports 41.0% against 41.0% in Indonesia, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Indonesia ahead.
Bangladesh ranks 131st and Indonesia ranks 131st of 143 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 1.1% | 0.0% | — |
| 2010s | 14.1% | 11.9% | 2.2% | Bangladesh |
| 2020s | 34.2% | 30.6% | 3.6% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Bangladesh or Indonesia?
- Bangladesh, at 41.0% against 41.0% in Indonesia as of 2024.
- What is the difference in antiretroviral therapy coverage between Bangladesh and Indonesia?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Indonesia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Indonesia rank globally for antiretroviral therapy coverage?
- Bangladesh ranks 131st and Indonesia ranks 131st of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.